Drugdiscovery >> Clinical Trials >> News
5944
Views
title
FDA grants Fast Track designation for Galectin’s liver drug - drugdiscovery.com


The drug, GR-MD-O2 (galactoarabino-rhamnogalacturonate), is now tested in phase I clinical trial for treatment of patients with fatty liver disease and advanced fibrosis. Preclinical data shown that GR-MD-02 has promising effects in reversing fibrosis and cirrhosis.
Read More >>


Tags: Galectin Therapeutics, fatty liver disease, liver, clinical trials, FDA approval, fast track designation - August 13, 2013
Related Articles
17948
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

4960
Views
Prophylaxis of organ rejection and prophylaxis of fungal infections in liver transplant patients - new insights Prophylaxis of organ rejection and prophylaxis of fungal infections in liver transplant patients - new insights
The results of several studies provide new insights and considerations for immunosuppressive treatment and treatment of fungal infections in liver transplant patients. Read More >>

Tags: liver transplantation, organ rejection, fungal infection, immunosuppressive treatment

5387
Views
New Alzheimer drug enters Phase 3 program New Alzheimer drug enters Phase 3 program
Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different Read More >>

Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial

21265
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

1636
Views
Phase III trial of Amgen's drug was an outstanding success Phase III trial of Amgen's drug was an outstanding success
Evolocumab, the new drug of Amgen has gone through Phase III. clinical trial. The result is a statistically significant reduction in low-density lipoprotein cholesterol. The new drug seems to be 66% m Read More >>

Tags: drug, competitior, cholesterol, Amgen

4976
Views
Theravance’s experimental COPD drug meets study goal Theravance’s experimental COPD drug meets study goal
Theravance announced that the drug, named TD-408, taken as a once-per-day treatment for moderate to severe chronic obstructive pulmonary disease met its goals in a midstage clinical trial. Read More >>

Tags: Theravance, experimental drug, COPD, lung disease, clinical trial

6119
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

6428
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

16485
Views
Novel brain cancer drug proceeds to the Phase II clinical trial Novel brain cancer drug proceeds to the Phase II clinical trial
The major obstacle for the treatment of malignant brain diseases is the protective blood-brain barrier (BBB), which restricts drug delivery into the central nervous system. To circumvent this issue, a Read More >>

Tags: blood-brain barrier, brain tumor, brain cancer, drug delivery, doxorubicin, G-Technology, liposome

8500
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013